Akoya Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Akoya Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29% to $96,633,000. The net income raised on -$63,323,000 and profit margin reached -66%. Total operating expenses were $104,270,000.

Profit Margin

Akoya Biosciences, Inc. (NASDAQ:AKYA): Profit margin
2019 42.23M -14.75M -34.93%
2020 42.44M -16.70M -39.36%
2021 54.91M -42.93M -78.18%
2022 74.85M -70.64M -94.37%
2023 96.63M -63.32M -65.53%

AKYA Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
96.63M74.85M54.91M42.44M42.23M
Cost of revenue
40.32M31.46M20.69M16.53M17.57M
Gross profit
56.30M43.39M34.21M25.90M24.66M
Operating exp.
Research and development
21.88M23.21M15.70M9.60M8.76M
Selling and marketing
0000900K
Total operating expenses
104.27M109.59M71.44M37.4M38.16M
Operating income
-57.66M-66.20M-37.22M-11.49M-13.50M
Other income (expenses), net
-5.61M-4.31M-5.85M-4.65M-1.05M
Income before tax
-63.28M-70.51M-43.07M-16.66M-14.55M
Income tax expense
40K123K-140K42K194K
Net income
-63.32M-70.64M-42.93M-16.70M-14.75M
Earnings per share
Basic EPS
-1.43-1.87-1.15-0.45-0.4
Diluted EPS
-1.43-1.87-1.15-0.45-0.4
Data sourceData sourceData source